Synergy Pharmaceuticals: Monday's Pipeline News Strengthens Company At Its Core

Long Investing Ideas from Seeking Alpha

Tue, 23 Oct 2012

By VFC : A little over a month ago , Synergy Pharmaceuticals, Inc. ( SGYP ) announced that it had filed an Investigational New Drug with the FDA for a second GI pipeline candidate, SP-333 - an announcement that piqued investor interest in this company's ability to potentially become a big player in ...

Read the rest of this article on Long Investing Ideas from Seeking Alpha

Related Topics:

Content Partners

Site Directory Site Map Our Products

Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News

International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland

Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.